![Peter Emtage](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter Emtage
Fondateur chez
Santa Ana Bio, Inc.
Profil
Peter Emtage is the founder of Santa Ana Bio, Inc. Dr. Emtage is currently a Venture Partner at Versant Venture Management LLC since 2021.
Formerly, Dr. Emtage was Director at Kyverna Therapeutics, Inc., Vice President-Immunotherapy at MedImmune LLC, Vice President-Research & Development at Nventa Biopharmaceuticals Corp., Vice President-Synthetic Immunology at Precigen, Inc., and Chief Scientific Officer at Femta Pharmaceuticals, Inc. Dr. Emtage completed undergraduate and graduate degrees at the University of Guelph and earned a doctorate from McMaster University.
Postes actifs de Peter Emtage
| Sociétés | Poste | Début |
|---|---|---|
Versant Venture Management LLC
 Versant Venture Management LLC Investment ManagersFinance Versant Ventures invests in biotechnology companies located globally. The firm participates in early and later stage capital requirements. | Private Equity Investor | 01/10/2020 |
Santa Ana Bio, Inc.
 Santa Ana Bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which focuses on precision immunology for autoimmune diseases | Fondateur | - |
Anciens postes connus de Peter Emtage
| Sociétés | Poste | Fin |
|---|---|---|
| KYVERNA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 26/01/2022 |
MedImmune LLC
 MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Corporate Officer/Principal | - |
Femta Pharmaceuticals, Inc.
 Femta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops antibody therapeutics | Directeur Technique/Scientifique/R&D | - |
| PRECIGEN, INC. | Corporate Officer/Principal | - |
Nventa Biopharmaceuticals Corp.
 Nventa Biopharmaceuticals Corp. Medical SpecialtiesHealth Technology Discovers, develops and commercializes innovative stress protein-based therapeutic vaccines | Directeur Technique/Scientifique/R&D | - |
Formation de Peter Emtage
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
8
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Nventa Biopharmaceuticals Corp.
Nventa Biopharmaceuticals Corp. Medical SpecialtiesHealth Technology Discovers, develops and commercializes innovative stress protein-based therapeutic vaccines | Health Technology |
Precigen, Inc.
 Precigen, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company | Health Technology |
University of Guelph
 University of Guelph Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
McMaster University
 McMaster University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Ventures invests in biotechnology companies located globally. The firm participates in early and later stage capital requirements. | Finance |
Femta Pharmaceuticals, Inc.
Femta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops antibody therapeutics | Health Technology |
Kyverna Therapeutics, Inc.
 Kyverna Therapeutics, Inc. BiotechnologyHealth Technology Operates as a cell therapy company which develops treatments and potential cures for serious autoimmune diseases | Health Technology |
Santa Ana Bio, Inc.
Santa Ana Bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which focuses on precision immunology for autoimmune diseases | Health Technology |
